LONGMONT, Colo.--(BUSINESS WIRE)--Chemizon (KOSDAQ: 010170) announced today that it has signed an agreement with Array BioPharma (NASDAQ: ARRY) to provide Array with various medicinal chemistry services including chemical synthesis and new route research. Chemizon’s technical team will support Array’s internal chemistry capabilities, providing Array with a reliable, external partner to meet aggressive timelines.
